ABSTRACT This paper proposes a method that extracts a feature set for accurate disease diagnosis from a feature (aptamer) array. Our method uses an artificial intelligence of the neural network and 10-fold crossvalidations and is verified by the p-value of the aptamer array response to specimens of 80 liver cancer patients and 310 healthy people. The proposed method is compared with the one-way ANOVA method in terms of accuracy, the number of features, and computing time to determine the feature set required to achieve the same accuracy. An increase in the number of features dramatically improves the diagnosis accuracy of the two methods for 2-10 features. The accuracies with 10 features are 93.5% and 87.5%, and the increases in accuracy per additional feature are 3.39% and 2.65% for our method and the one-way ANOVA, respectively. For the same accuracy, our method needs only 1/2-1/3 number of features of the ANOVA. An interesting statistical characteristic of cross-validation is that diagnostic accuracy saturates after 10 000 cross-validations.
I. INTRODUCTION
Many researchers in various fields have made great efforts to develop an accurate and simple disease diagnosis method. Currently, one or two features (markers) are used in disease diagnosis based on the response of features to a specimen. However, we cannot guarantee accurate and robust diagnosis for all diseases with one or two features. It is especially difficult to make a determination from a limited number of features when trying to diagnose a disease in its early stages. Recently, many researchers have invested effort in resolving the problem using microarrays, which have a massive number of features [1] - [3] . A microarray consists of tens of thousands of different sensing points, which react with specimens such as human serum. There are two reasons that numerous features are used. The first is that we do not know what combination of features is effective or useful for diagnosis of a specific disease. The second is that we can make a more accurate decision as more features are used for diagnosis. However, the micro-array method requires considerable resources and time to diagnose a disease with numerous features at every single step of a clinical test. In addition, there is the possibility that a microarray could have ineffective features and could lower the accuracy of a diagnosis. Therefore, we need a method to find a compact but accurate and reliable feature set from the feature array for a disease. The feature selection methods can be classified into three categories: the filter approach, the wrapper approach, and the hybrid approach [4] . In this paper, we propose a hybrid approach that uses a p-value from analysis of variance (ANOVA), neural networks (NNs), and crossvalidation (CV). The p-value is a type of filter approach, and is widely used to select useful features in microarrays [5] , [6] . The NN, which uses artificial intelligence by machine learning, or training with independent datasets is widely used to make a decision in ambiguous situations such as disease diagnosis. The NN is also widely used for the wrapper approach as a learning model. The most conventional wrapper approaches focus on optimizations and manipulations of learning algorithms or networks. The proposed method focuses in this paper on how to obtain a compact and reliable feature set from big data based on a neural network and the CV method. The CV method can increase the credibility of the selected feature set due to various combinations of specimens.
The introduction is followed by a brief review of NNs, the working principles of the proposed feature selection method, an experimental investigation with real clinical data, and a series of discussion topics based on the experiment results.
II. NEURAL NETWORK ALGORITHM
This paper proposes a feature selection method for liver cancer based on an NN and CV that is accurate, compact, and reliable. An NN is a nonlinear feedback system that adjusts weights between layers to produce outputs corresponding to a given input set. The NN accumulates artificial intelligence for the diagnosis of a specific disease by repeating weight adjustments with many independent input and output datasets. The performance of an NN depends on its structure, and is beyond the scope of this paper; however, we may obtain information on the subject from the literature [7] - [12] . The NN used in this paper consists of three layers: k-th input nodes, 10 hidden nodes, and 2 output nodes, as shown in Fig. 1 . It also uses an error backpropagation algorithm to adjust the weights of the network for the given inputs and outputs [13] , [14] . The basic working principle of the NN shown in Fig. 1 is as follows. The input layer receives the measured value of the feature reaction (x k ) as input; the hidden layer consists of 10 nodes, which multiplies inputs by weights (W jk ); and the output layer generates results by processing the output values of the hidden nodes. There are two possible outputs: probability of liver cancer (y 0 ) and normal (y 1 ). The value of the k-th node (h k ) in the hidden layer is given by (1):
where n represents the number of inputs, and w jk denotes the weight between the j-th input and the k-th node in the hidden layer. An activation function, as in (2) , prevents an overflow of the node values in the hidden and output layers, and f (h k ) is obtained from the node values in the hidden layer
Output (yt m ) is obtained by multiplying f (h k ) with weight factor (hw km ), as is done in (3) .
where m represents output nodes with a value of either 0 or 1. The final output, y m , is determined with f (yt m ), which is obtained by using an activation function as in (2) . An NN adjusts the weights between layers using error backpropagation to obtain corresponding outputs from the given input data. To obtain the output, an NN calculates weighting factors (w jk , hw km ) between layers by using input data and previous weighting factors. The error backpropagation method adjusts the weights from the output layers to reverse the direction, thus the weighting factor (hw km ) between the output and hidden layers is obtained with (4) first.
where hw km (t) is the current weight, and hw km (t + 1) is the new weight to be updated. hw km is expressed in (5) .
where ρ is the learning rate, which has a value of 0 < ρ < 1. If this rate is too small, the learning speed could be slow. In case of a large ρ, the learning process may not convers. As mentioned earlier, y m in (5) is the final output value of the output nodes. The value of y m represents the result of the NN, and is a real number between 0 and 1 because it is obtained from a sigmoid function. δ m in (5) is the error between expected and calculated outputs, as calculated with (6):
Here, y t means expected output of the input. In this paper, a liver cancer specimen is y 0 = 1, y 1 = 0, and a normal specimen is y 0 = 0, y 1 = 1. After adjusting the weight between output and hidden layers (hw km ), weights between hidden and input layers (w jk ) are obtained with (7):
Here, j represents the number of input nodes. w jk is obtained by using (8) , and ρ and y m have the same values, which are used for adjusting weights between output and hidden layers.
where δ k , which is the error of the k-node in the hidden layer, is expressed as (9):
δ m is the error between the output and hidden layers, obtained previously. Following the procedures mentioned VOLUME 6, 2018 above makes the NN more intelligent from repetitive weight adjustments when using enough specimens with known results, and therefore can make an accurate decision for new specimens.
III. PROPOSED METHOD
The proposed method uses the learning ability of the NN to eliminate features from a massive set of features without sacrificing diagnosis accuracy. Many conventional approaches to artificial intelligence focus on the architecture of the NN and the learning parameters for the best machine learning [7] - [12] . Even if the optimal architecture and learning parameters of an NN are determined, extra effort is needed to obtain a compact, accurate, and reliable feature set from big data on the order of 10 300 cases. For example, it would require several years to determine a feature set with the optimal architecture of an NN and a supercomputer from a dataset of 10 300 cases without an efficient method for determining a good feature set. It is acceptable to expend reasonable time on finding a good feature set from big data, however, several years with a super computer is not practical. This work suggests a method that can find a compact set of reliable and accurate features for liver cancer from a dataset of size 10 300 in the reasonable time. The basic concept of the proposed method is to check the accuracy of diagnosis by adding up the features, one by one, and selecting features that improve the accuracy; otherwise, the feature is removed from the feature set. The proposed method consists of four steps, as shown in Fig. 2 . In the first stage, pre-screening is carried out to arrange features in ascending order of p-value with respect to the possibility of usefulness for diagnosis. In the second stage, the select-eliminate (S-E) algorithm selects the useful features from among those in the pre-screening stage. In this stage, the process is performed with many CVs to get the frequency of appearance of a feature in a high-ranking feature set. This step takes most of the time in the proposed method because we use many CVs to improve the credibility of the proposed method. In the third stage, the features are re-arranged in descending order by frequency of appearance at higher rank from the second stage. In the last stage, the feature set from the 3 rd stage is divided into subgroups, and then the diagnosis accuracy is investigated by adding subgroups one by one. Finally, the feature set is determined by adjusting the number of features in the subgroup bundles, which gives the best analysis accuracy. To increase the credibility of the selected feature set, the CV method is adopted in all the steps.
A. PRE-SCREENING STAGE
If we select randomly a feature set from numerous features, it will take an exceedingly long time and diagnosis accuracy cannot be guaranteed. To resolve these problems, we need to arrange the features in ascending order of their usefulness in diagnosis. Many pre-developed algorithms can be used for the pre-screening step [15] - [19] . In this paper, we use the one-way ANOVA, which is widely used in microarray data processing [6] , [20] , as a pre-screening tool. Generally, the p-value is used as a reference parameter to determine whether the measured data from an experiment are useful or not when drawing a conclusion in bio-signal processing [5] . The p-value used in this paper is thought of as a correlation between normal and abnormal specimens, and it is determined by a statistical treatment of the response of a feature to a normal specimen and an abnormal specimen. The smaller the p-value of a feature is, the better the feature can distinguish between normal and abnormal specimens. In the prescreening stage, we obtain p-values of each feature using a one-way ANOVA and arrange the features in ascending order by p-value.
B. S-E STAGE
In this stage, the NN obtains artificial intelligence by learning disease diagnosis from the features sorted in ascending order by p-value. The artificial intelligence of the NN improves during the learning process by adding elements from the pre-screening stage. The diagnosis accuracy of each learning process is used as the criteria for selecting or eliminating the element in the feature set. We use an n-fold CV method for the NN system to systematically obtain artificial intelligence. The n-fold CV is a cross-blind test method that divides all specimens into n groups with the same number of samples. The (n-1) groups out of n groups are used for system learning, and the last group is used for a blind test [21] , [22] . The diagnosis accuracy is the average value of many CVs. The basic concept of the S-E method is to select a feature when the diagnosis accuracy is the same or improved-in comparison to the previous accuracy before the addition-after adding that feature. The method will be described in more detail in subsections 1) and 2), and with Fig. 3 .
1) GROUPING FOR CV
For CV, we divide specimens into normal and abnormal. After that, we put all specimens into n groups for an n-fold CV. In this step, each group has the same normal-to-abnormal ratio, and the number of specimens in a group is more than the number that a Gaussian distribution is capable of handling. According to the central limit theorem, a Gaussian distribution can be created with more than 30 samples [23] , however, the minimum number of features for Gaussian distribution was determined by experiment in this study.
2) S-E ALOGRITHM
To perform the S-E method, the first feature of the (n-1) groups, sorted in the pre-screening step, is used for the first NN learning. After the learning process is completed, the diagnosis accuracy is obtained by performing a diagnosis for the group that is not included in the (n-1) groups, based on the intelligence acquired from the first learning. The accuracy from the first diagnosis is saved, and the first feature is naturally included in the feature set, as seen in Fig. 3 . In the next step, the first and second features of the (n-1) groups are used as learning features, and then the average diagnosis accuracy of the rest group is obtained. Using the results, if the accuracy is found to have improved or equals the results of the first experiment, the second feature is included in the feature set. Otherwise, the second feature is eliminated. We performed the S-E process using as many features as desired in order to obtain a feature set. The NN, introduced in Section II, consists of many complicated non-linear functions; therefore, we cannot obtain the best accuracy with only a combination of features that have high distinction (i.e., a low p-value). Moreover, the accuracy does not always improve by adding new features to a feature set. In some cases, adding features lowers the accuracy. Therefore, we combine features in a way to obtain the best accuracy. In the method presented up to now, there is no possibility of combining high-ranked features with low-ranked ones due to the elimination of the highranked features in the early experiments. The features that have high distinction (a low p-value), may be excluded from a feature set just because of unlucky combinations. To resolve this issue, we perform the S-E process one more time to add up the eliminated features, as shown in the rightmost loop (r++, m = 2) in Fig. 3 . After all the processes have been completed, we obtain a feature set that has a high possibility of providing the best accuracy.
C. REARRANGE THE FEATURES FROM MANY S-E EXECUTIONS
The feature set from the S-E process has a problem: the diagnosis accuracy depends on the grouping method for CV. To resolve this problem, we obtain feature sets by performing S-E many times, with independent CVs, as seen in Fig. 3 . The features that are frequently included in each feature set could offer a better possibility of an accurate diagnosis. Therefore, we obtain feature sets through many independent CVs and obtain the frequency of appearance of each feature selected in a feature set, as seen in Fig. 4 . Finally, we rearrange the features in descending order of the frequency of appearance. The more CV executions we perform with many features, the more general feature sets we can obtain. Many clinical data, i.e. many features and specimens, could give us a lot of learning experience and CV cases, but require excessive computing time. In this study, the number of cases that we must analyze is determined with consideration for execution time. The realistic approach is to experimentally obtain a reliable feature set with enough clinical data and highperformance computing within an acceptable time without sacrificing diagnosis accuracy.
D. DETERMINATION OF CANDIDATE FEATURE SET
The accuracy cannot improve monotonically by increasing the number of features that have a low p-value because an NN consists of a combination of many non-linear functions. The ideal case is to obtain a feature set that gives 100% diagnosis accuracy, however, which is practically impossible. The second-best approach is to check the accuracy through every combination of the pre-determined feature set; however, it is impossible to carry out calculations for all combinations, considering the computation time. Therefore, we have to constitute a feature set that yields the best accuracy by using the appropriate method with a reasonable number of features. The feature set is determined through a rough search and a detailed search, as shown in Fig. 5 . 
1) ROUGH SEARCH
The features, which are sorted based on the frequency of selection as an element of a feature set, are divided into many groups of the same size in the first step of the rough search. Then the diagnosis accuracy is investigated by adding subgroups one by one in a sequence of highly-ranked groups. For example, if a group consists of 16 features, we select the first 16 features and let the NN develop artificial intelligence with those 16 features and get the average accuracy of 16 features from many CV processes. In the next step, we add the 2nd ranked group to the 1st ranked group and do the same analysis as was done with the first 16 features. In this way, the average accuracy of all analysis units is determined. The rough search stops at the first appearance of target accuracy, and the unit (''P'' in the lower part of Fig. 5 ) is selected as the starting number of features in the next detailed step, as seen in Fig. 5 .
2) DETAILED SEARCH
In the detailed search, we obtain diagnosis accuracy by precisely increasing or decreasing the number of features around the number of features (''P'') from the rough searches. It is similar to the bisection method in numerical analysis. If the number of features is increased by N as 1 unit in a rough search, we change the analysis number of features by adding or subtracting by ±N/2, ±(N/4), ±(N/8), . . . , 1 from the number (''P'') determined in the rough search. To determine a feature set that gives the best accuracy, a detailed search is repeatedly carried out until the increment in the number becomes 1, as seen in Fig. 5 . There are also many learning processes and CVs in each detailed analysis step.
IV. EXPERIMENT A. PREPARATION OF CLINICAL DATA
For verification of the proposed method, we obtained a dataset with a microarray that consists of 751 different aptamers. An aptamer is a type of feature introduced in Section II, and aptamer spots in the microarray are reacted with human serums. An aptamer labeled with fluorescent dye can measure the relative amount of a specific protein in a serum because different color and light intensity will be emitted depending on the amount of a specific protein in the serum [24] - [26] . We can diagnose liver cancer from the light information of each aptamer spot in the microarray because there may be more or less of a specific protein in the liver cancer patient's serum. The spots, which consist of 751 different aptamers, are reacted with 310 normal serums and 80 serums from the liver cancer patients. Then scanning image of the array and the image analysis of each spot were carried out in sequence.
B. PRE-SCREENING
When we have an aptamer array reacting with 310 normal and 80 liver cancer specimens, it is difficult to obtain consistent results owing to changes in environmental conditions, such as temperature, humidity, and reaction times. In order to overcome these problems, the data were adjusted through pre-processing and normalization. Subsequently, we obtained p-values of 1,141 aptamers by using a one-way ANOVA. Based on this p-value information, we selected 751 aptamers that had a p-value less than 0.05, and sorted them in ascending order based on the p-value. Generally, if data have a p-value under 0.05, the data are regarded as having a valid value in bio-signal processing [6] . 
C. S-E 1) DETERMINATION OF GROUP SIZE FOR CV
If the sample size of a group is too small, the standard deviation of the data could be large, and the CV could be meaningless. In this study, we experimentally determined the proper number of specimens of each group for CV. For this decision, we analyzed the maximum value of the standard deviation of the p-value of the first feature corrected and normalized in Section IV.B. As a result, the maximum standard deviation of a group almost saturated when the number of samples was more than 35, as seen in Fig. 6 . Based on this result, we determined that the size of each group should be 39 specimens, consisting of 31 normal and 8 liver cancer specimens from our data of 310 normal and 80 liver cancer specimens, as seen in Fig. 7 . We performed 10-fold CV because we had 10 groups consisting of 39 specimens each.
2) DEFINITION OF ACCRUACY
The S-E algorithm strives for improvement in diagnosis accuracy by adding one feature, and then determining whether to include that feature in the feature set based on the result. In this study, accuracy means the probability of making the right decision through the trained NN. The proposed method inputs the p-values of each spot and outputs two values, y 0 and y 1 , which are the possibility of normal and abnormal, respectively. The algorithm also compares y 0 and y 1 to make a final decision. When y 0 > y 1 , it means the result of the diagnosis is liver cancer. When y 0 < y 1 , it indicates a normal specimen. If y 0 = y 1 , it is regarded as a misclassification. We use the designation 'a' when a liver cancer specimen is used and the final decision is liver cancer. We use the designation 'b' when a normal specimen is used and the final decision is normal. Finally, (a + b) divided by K (the number of tested specimens), as in (10), is used for diagnosis accuracy in this study.
When we execute the S-E algorithm, the useful aptamers for a group as determined through a CV process are included or excluded in the feature set. According to the results of the S-E process with 751 features, 71 aptamers were, on average, selected by each S-E execution.
D. REARRANGING THE FEATURES FROM MANY S-E EXECUTIONS
One S-E process requires many operation cycles. The learning process was carried out 10 times with 751 aptamers and 351 specimens in 9 groups, and the decision process used the data of 39 specimens in the last group for the 10-fold CV step. To obtain a feature set that gave a good average accuracy we performed the S-E process 1,000 times using the 10-fold CV with randomly-generated groups. Subsequently, we rearranged the features in descending order based on the number of times a feature was selected into a feature set. The feature set, which was sorted by one-way ANOVA and had 100 features, was re-sorted by the S-E algorithm of the proposed method, and the result is shown in Table 1 . A total of 19 features ranked within 100 in ANOVA set go to out of 100-rank in the many select-elimination process. The ranks from this process are more reliable than the one-way ANOVA because they are determined by many CV processes. The details of the results will be discussed in subsections E and F of this section.
E. DETERMINATION OF A FEATURE SET 1) DETERMINATION OF THE NUMBER OF 10-FOLD CV EXECUTIONS
This work uses a dataset made from the reactions of 751 aptamers to 310 normal and 80 liver cancer specimens. Let us consider the number of grouping cases for the 10-fold CV from our dataset. The number of grouping cases for normal specimens and liver cancer specimens are calculated in (11) and (12), respectively. Therefore, the total for all the cases that cover all the CVs in this work is calculated by (13) cases is impossible. The computing time required for 10-fold CV will be discussed in subsection G of this section. We analyzed the variation in accuracy depending on the number of CV executions. For this experiment, we used a highperformance computing system, and the result is shown in Fig. 8 . The y-axis of Fig. 8 represents the normalized value of the accuracy variation. According to the result, the variation in accuracy is almost saturated with more than 10,000 CVs. We performed 10,000 CVs to obtain a greater margin in the accuracy variation based on this result.
2) GETTING THE BEST ACCURACY
We rearranged the features according to frequency of appearance in the feature set from 1,000 S-E executions with the method introduced in subsection C of Section III. The number of execution times, i.e., 1,000, is determined by checking the maximum change in rankings vs. S-E execution times. The maximum ranking change is within 3 for 1,000 S-E processes. The number of S-E executions (1,000) was determined by taking into consideration execution time and effectiveness. After that, we performed a rough search and a detailed search using the 200 highest-ranked features. In the rough search, we increased the number of features by eight, and obtained diagnosis accuracy for each case, as seen in Table 2 . The reason that features ranked lower than the top 200 were not used is that there is negligible improvement in diagnosis accuracy 78220 VOLUME 6, 2018
by adding these features. The first 99.0% accuracy appears at 168 features, as shown in Table 2 . The detailed search is carried out by adding or subtracting ±4, ±2, and ±1 from 168, and then 99.1% accuracy is acquired with 161 features.
V. RESULTS AND DISCUSSION

A. ACCURACY COMPARISON
The accuracy of the proposed method was compared with that of one-way ANOVA, which is widely used in disease diagnosis. The rough search for 10,000 CVs and detailed search were carried-out with the datasets from the S-E step of our method and the one-way ANOVA. The accuracy of each method vs. the number of features is shown in Fig. 9 for fewer than 40 features. According to Fig. 9 , the diagnosis accuracy improves for both methods as the number of features increases for the NN diagnosis system. We can confirm from this trend that NN systems with many features can give us much better accuracy than a single feature. The following can be seen in Fig. 9 : the accuracy of the proposed method is better than that of the one-way ANOVA for all numbers of features, and improves almost monotonically by adding features to the feature set; however, the one-way ANOVA does not always show monotonic trends. This phenomenon is due to the fact that the ANOVA method does not consider improving the accuracy according to the combination of features. An increase in the number of features in the range of 2-10 features dramatically improves diagnosis accuracy for both methods, and the average improvement per feature added for the proposed method and ANOVA is 3.39% and 2.65%, respectively, as shown in Table 3 . The proposed method is superior to the ANOVA and shows a 10% improvement in the average accuracy for 2-10 features as shown in Table 4 . This dramatic improvement in accuracy shows that using multiple features can improve accuracy even with low-discriminating feature. Let us consider the number of features for the same accuracy in two methods. Our method needs only 1/2-1/3 of the features for an ANOVA as in Table 5 . The proposed method needs 35 features for 98% accuracy; however, the ANOVA method needs 104 features for the same accuracy. As an extreme example, in order to achieve 98.6% accuracy, our approach requires 35 features and ANOVA requires 336 features which are nearly 10 times that of our approach. The accuracy of the two methods is the same when the number of samples is 1 or 2 because the p-value of 2 samples is small and the discrimination power is high, as shown in Table 3 , 4 and Fig. 9 . The above-mentioned viewpoints, i.e., the accuracy and the required number of features, and the proposed method VOLUME 6, 2018 are superior to the one-way ANOVA method. The reason why our method is better than the ANOVA is that our method gives higher rank in the select-elimination step for the features that have a higher probability of increasing accuracy combined with others, but ANOVA sorts features only by the p-value without considering the nonlinearity characteristics of NNs nor possibility of improvement of accuracy by combination of other features. The proposed method is disadvantageous in terms of computational complexity than the one-way ANOVA method. The computation complexity will be discussed in the rest of this section. 
B. CONSIDERATION OF THE RUNNING TIME
The fundamental operations of our method are training with NN and CV process. Operation cycles are proportional to the number of inputs for the NN and the cases of CVs. To get the run time for the fundamental operation, we do experiments with an Intel i5 3.4 GHz CPU single-core (thread) PC, as shown in Table 6 . We derived an equation (14) to calculate run time in seconds based on Table 6 . (14) where NCV and, i represent number of CVs and the number of inputs to the NN. The operation cycles of each step for the two methods are summarized in Table 7 and the symbols are defined as follows: NSE = number of S-E operations, m = average operations of S-E to find a useful feature, k = number of features acquired per single S-E operation, N = number of blocks the detail search starts, BL = block size of the rough search, and O = number of features for detail searches and O and X means necessary and unnecessary. The operation cycles for the S-E and rough search steps require the most cycles for both methods, and their complexity is o(i 2 ). According to the experiment in section IV-E-1, the accuracy saturates when the CV cases is greater than 10,000, thus it is not necessary to increase the CVs to greater than 10,000. When there are a large number of inputs, the effect of the CV step on the operation cycle is not significant, but rather, the inputs to the NN significantly affect the computer runtime.
Time of fundamental operation
As can be seen in Table 7 , the amount of computation is mainly determined by the number of fundamental operations, the number of features, and the number of S-E operations. According to Table 5 , we need 35 and 104 features for 98.0% accuracy with the proposed method and ANOVA, respectively. It took 61.5 and 11.5 days to find the feature set for 98.0% accuracy on PC mentioned previously with the proposed method and the ANOVA, respectively. It is worth spending time to find an efficient feature set, because once the feature set is determined, we do not need to find a new feature set for a disease diagnosis. From an economic point of view, taking a long time to determine a set with a few features is better than many features used in diagnosis. We used a super computer at the Korea Institute of Science and Technology (KIST) to find a feature set in a reasonable time. The system was equipped with Intel Xeon 2.5 GHz CPU-144 nodes (threads), Intel Xeon 2.6 GHz CPU-512 nodes, and Intel Xeon 2.53 GHz CPU-488 nodes. We managed the required calculations in approximately 4.5 days for 98.0% accuracy feature set using a message-passing interface (MPI), which is parallel programming with many threads. It is worth running a computer several days to find an efficient feature set, because once the feature set for a disease diagnosis is determined, we do not need to find a new feature at the hospital and it takes few seconds to make a diagnosis with the pre-determined feature set, even if it has several tens of features. From an economic point of view, spending offline a long time to find a compact and reliable feature set is better than many features used in real diagnosis at the hospital.
VI. CONCLUSION
We suggest a feature selection method for disease diagnosis using the p-value, the artificial intelligence of a neural network, and 10-fold CV. The neural network obtains artificial intelligence by learning pre-determined disease diagnosis results. The features are sorted in ascending order of p-value, and the S-E algorithm adds a feature one by one from the presorted features, which improves the diagnosis accuracy of the feature set. The S-E steps are carried out with 1,000 10-fold CVs, and then the features are sorted in descending order based on the frequency of appearance in the feature set. Finally, the proposed method determines a feature set via rough and detailed searches with 10,000 10-fold CVs. The proposed method is compared with the one-way ANOVA method with respect to accuracy, number of features, and computing time to determine a feature set for the same accuracy. We used the raw clinical data from the responses of 751 aptamer arrays to serums of 80 liver cancer patients and 310 healthy people. An increase in the number of features dramatically improves diagnosis accuracy in both methods for between 2 and 10 features. The accuracies with 10 features are 93.5% and 87.5%, and the improvements per additional feature are 3.39% and 2.65% for our method and the one-way ANOVA, respectively. For the same accuracy, our method needs only 1/2-1/3 of the features of the ANOVA. The reason why our method is superior to the ANOVA is that our method selects features that will possibly have good diagnosis accuracy in combination with other features through the S-E step. An interesting statistical characteristic of CV process is that diagnostic accuracy saturates beyond 10,000 CVs. We can dramatically save computing time to obtain a reliable feature set by using this characteristic to reduce the astronomical number of CVs to 10,000. The combination of the proposed method and neural networks that have better performance than that used in this study may improves diagnosis accuracy and compact the feature sets for various diseases.
APPENDIX
This is pseudo-code for the proposed method.
Select-Elimination ( { Generate 'feature set' with 'i' features from re arranged features; FOR(j=1 to 'the maximum CV execution times') { Make 'n' group using random function from 'data set'; Get accuracy of each group using 'n' fold CV with 'feature set'; } Get the average accuracy of using 'feature set'; } Save the number of features giving the best accuracy to'P'; Update N = N / 2; Update 'the maximum number of features' = P + N; Update m = P -N; } WHILE(N >= 1); Get the 'feature set' with 'P' features;
